Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.-Reference-Cited by-同舟云学术

Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.

Published:1994-07-05 Issue:14 Volume:91 Page:6599-6603
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Balzarini J.,Karlsson A.,Sardana V. V.,Emini E. A.,Camarasa M. J.,De Clercq E.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De novo design based identification of potential HIV-1 integrase inhibitors: A pharmacoinformatics study;Computational Biology and Chemistry;2020-10

2. Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine;Antimicrobial Agents and Chemotherapy;2013-04-22

3. Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase;Antimicrobial Agents and Chemotherapy;2012-01-17

4. Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies;JAIDS Journal of Acquired Immune Deficiency Syndromes;2012-01-01

5. HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors;Antiviral Research;2011-11